Covaxin trials begin at AIIMS
The All India Institute of Medical Sciences (AIIMS) in Delhi is scheduled to start phase I/II of human clinical trials of the indigenously developed Covid-19 vaccine candidate 'Covaxin' on 20 July 2020.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/24545-covaxin-trials-begin-at-aiims.html
#Covaxin #AIIMS #DCGI #NIV #Covaxintrials
The All India Institute of Medical Sciences (AIIMS) in Delhi is scheduled to start phase I/II of human clinical trials of the indigenously developed Covid-19 vaccine candidate 'Covaxin' on 20 July 2020.
Read More: https://www.ksgindia.com/study-material/news-for-aspirants/24545-covaxin-trials-begin-at-aiims.html
#Covaxin #AIIMS #DCGI #NIV #Covaxintrials
Ksgindia
Covaxin trials begin at AIIMS | KSG India | Khan Study Group
The All India Institute of Medical Sciences (AIIMS) in Delhi is scheduled to start phase I/II of human clinical trials of the indigenously developed Covid-19 vaccine candidate 'Covaxin' on 20 July 202
Watch: Covaxin gets DCGI nod for emergency use for kids aged 12-18 years #prelimsbooster #KSG #explainer
https://www.youtube.com/watch?v=bH_H0GUHMr8
https://www.youtube.com/watch?v=bH_H0GUHMr8
YouTube
Covaxin gets DCGI nod for emergency use for kids aged 12-18 years #prelimsbooster #KSG #explainer
#DCGI #Covaxin #vaccineforkids #KSGExplainer #Coronavirusupdates
Covaxin gets DCGI nod for aged 12-18 years
GS Paper - 2 (Diseases)
Indigenously developed Covid-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI)…
Covaxin gets DCGI nod for aged 12-18 years
GS Paper - 2 (Diseases)
Indigenously developed Covid-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI)…